Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP

Clinical trial NCT06859099 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06859099
Sponsor: Sanofi
Status: ENROLLING_BY_INVITATION
Phase: Phase 3
Study type: INTERVENTIONAL

Polyneuropathy, Inflammatory Demyelinating, Chronic

Start date: 2025-04-01
Primary completion: 2029-10-03
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.